Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of an Electronic Communication Platform to Activate Diabetic Patients Treated With Insulin

NCT04595383 is registered in ClinicalTrials.gov with Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana as lead sponsor.

NCT NCT04595383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04595383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of an Electronic Communication Platform to Activate Diabetic Patients Treated With Insulin
Lead sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2021
Completion date
May 31, 2022
Enrollment
106 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypoglycemia, hypoglycemia acute